Global biotech company CSL recently announced the winners of the 2023 CSL Behring Professor Heimburger Award, research grants that support the next generation of coagulation specialists and their novel research into hematological conditions.
Professor Dr. Norbert Heimburger, a CSL employee for over three decades, pioneered virus-safe plasma products based on pasteurization. In his honor, CSL created the Heimburger Award to support clinical and preclinical research that could improve the care of patients with bleeding disorders.
CSL Behring, a business unit of CSL, develops and manufactures medicines for bleeding disorders such as hemophilia and von Willebrand Disease. These bleeding disorders impact coagulation, how the body stops bleeding, an essential function – especially following injury or due to surgery.
Each grant recipient receives €25,000 (about US $27,000). Here are this year’s winners and a summary of their research areas:
Amanda Unsworth, Manchester Metropolitan University, Manchester, United Kingdom
Investigating: the contribution of novel regulators of the endothelium and coagulation to venous thrombosis
Pavan K. Bendapudi, Harvard Medical School, Boston, Massachusetts in the U.S.
Investigating: coagulation factor XII is activated via noncanonical binding to platelet integrin αIIbβ3
Olga Oleshko, Hannover Biomedical Research School, Hannover Medical School, Hannover, Germany
Investigating: immune complexes and bleeding in acquired hemophilia A
Sneha Singh, Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany
Investigating: unraveling proteome dynamics within the human fibrin clot
Dino Mehic, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Investigating: plasmin generation in patients with mild bleeding disorders and bleeding disorders of unknown cause
Learn how to apply for a Heimburger award for early career scientists researching coagulation, thrombosis and acquired bleeding disorders.
